Management of Bleeding Peptic Ulcer in Aspirin-Related Disease

Immediate Pharmacologic Management

• The American College of Emergency Physicians and the American Gastroenterological Association recommend starting intravenous PPI therapy immediately upon presentation, before endoscopy, to downstage the lesion and reduce the proportion of patients requiring endoscopic intervention at index endoscopy 1, 2
• PPI administration should not delay urgent endoscopy in actively bleeding patients, as recommended by the World Journal of Emergency Surgery 1

Endoscopic Evaluation and Treatment

• The American College of Gastroenterology recommends performing endoscopy within 24 hours of presentation to assess bleeding stigmata and provide therapeutic intervention if needed, with a strength of evidence rated as high 2, 3
• Endoscopic hemostasis is indicated for high-risk stigmata, including active bleeding or visible vessel, and should use combination therapy with thermocoagulation or clips plus epinephrine injection, as recommended by the Annals of Internal Medicine 1, 2

Post-Endoscopic PPI Regimen

• The World Journal of Emergency Surgery recommends administering a high-dose PPI protocol after successful endoscopic hemostasis for high-risk lesions, consisting of an 80 mg intravenous bolus followed by an 8 mg/hour continuous infusion for 72 hours, then transitioning to high-dose oral PPI, with a strength of evidence rated as moderate 1, 2

Critical Follow-Up Management

Aspirin Management

• The American Heart Association recommends restarting aspirin within 5-7 days after the bleeding episode, once hemostasis is confirmed, with a strength of evidence rated as high 2, 4, 5
• Continue aspirin with long-term PPI co-therapy to prevent recurrent bleeding, as recommended by the American College of Cardiology 2, 4, 5

Helicobacter pylori Testing

• The American Gastroenterological Association recommends testing all patients for H. pylori and providing eradication therapy if positive, with confirmation of eradication, with a strength of evidence rated as high 6, 7
• H. pylori eradication dramatically reduces rebleeding rates in peptic ulcer disease, as recommended by the European Helicobacter Study Group 6, 7

Long-Term PPI Therapy

• The American College of Gastroenterology recommends continuing PPI therapy long-term, given ongoing aspirin use, with a strength of evidence rated as moderate 1, 5, 8
• Patients with a history of upper GI bleeding who require ongoing aspirin therapy should receive indefinite PPI gastroprotection, as recommended by the American Gastroenterological Association 5, 8